The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment
BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD...
Saved in:
Main Authors: | Shawn D Aaron, Katherine Vandemheen, Dean Fergusson, Mark FitzGerald, Francois Maltais, Jean Bourbeau, Roger Goldstein, Andrew McIvor, Meyer Balter, Denis O'Donnell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2004/394710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Thoracic Society COPD Guidelines: Summary of Highlights for Family Doctors
by: Denis E O'Donnell, et al.
Published: (2003-01-01) -
State of the Art Compendium: Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease
by: Denis E O’Donnell, et al.
Published: (2004-01-01) -
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003
by: Denis E O’donnell, et al.
Published: (2003-01-01) -
What Is Unique about the New Canadian COPD Guidelines?
by: Denis E O'Donnell
Published: (2004-01-01) -
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
by: Denis E O’Donnell, et al.
Published: (2007-01-01)